At Novartis, we are reimagining medicine to improve and extend people’s lives. We are working hard to produce breakthroughs and address unmet needs for patients with devastating diseases, including genetic disorders and certain deadly cancers. We also are committed to ensuring our medicines reach as many people as possible.

We invite you to learn more about Novartis and our impact on patients, families and their communities. Every day we are working to improve human health and strengthen our society, as we strive to become the most valued and trusted medicines company in the world.

Grandfather hugging his grandson

Our purpose


Reimagine medicine to improve and extend people's lives.

Family looking at sunset

Our vision
 

Become the most valued and trusted medicines company in the world.

group-of-women-from-indigenous-community-health-workshop-colombia

Our strategy
 

Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Our footprint

5.1b

Total contribution of R&D activities to US Gross Domestic Product (GDP)

12,000+

Employees in the US from coast to coast

1.96m

Patients reached with our medicines in 2023


Young boy wearing stethoscope

Our Commitment to Patients & Caregivers

Our efforts on behalf of patients and caregivers, access principles, commitment to diversity in clinical trials, and Patient Assistance Programs.


 

Corporate Responsibility

Crowd outdoors

Population Health

Our commitment to improving population health in heart disease.

Learn more

 

Mature people smiling

The Novartis US Foundation

The mission of the Novartis US Foundation is to improve health in underserved communities in the United States.

Learn more

 

Kids running through sprinkler

Environmental Sustainability

At Novartis, we believe environmental sustainability is important to the sustainability of our business.

Learn more

 

Boy playing with dogs

Novartis in Society US Reports

Novartis is building a leading focused medicines company powered by advanced therapy platforms and data science.

Learn more